andrew huberman glp 1 semaglutide Hardaway, Ph.D., explains his research on GLP-1 weight loss drugs and how hormones influence brain circuits that regulate appetite and reward. Learn more at the link in our bio! GLP-1 Insights | Ask Huberman

Evidence ranges from international approvals and randomized trials to preclinical and community-use data

Inositol A B-vitamin-like compound that helps regulate insulin, supports fat metabolism, and may help reduce food cravings

Da li su APLB proizvodi na Numi.rs originalni

To reconcile the findings that both GIPR antagonists and GIPRAs reduce body weight, it is possible that physiological GIPR activity plays a permissive role in adipose tissue synthesis, while pharmacologically enhanced GIPR activity may reduce body weight through a different mechanism in the brain

Conflict of interest MG reports receipts of honoraria or consultation fees from Novartis, Eli Lilly, PierreFabre, Roche, and Organon and travel fees from Daichii Sankyo, all outside the submitted work